TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Inhaled Corticosteroids for the Treatment of Transient Tachypnea of the Newborn in Infants Born at >34 Weeks Gestation: A Prospective, Randomized, Double Blind, Placebo Controlled Study.
Brief Summary: Transient Tachypnea of the Newborn (TTN) is a common respiratory disorder affecting late preterm and term babies caused by lung edema resulting from delayed absorption of fetal alveolar lung fluid.

The investigators hypothesize that ENAC expression will be up-regulated as a result of administration of corticosteroids. This effect will lead to enhanced absorption of fetal lung fluid finally treating TTN. The aim of our study will be to evaluate whether inhaled corticosteroids reduce respiratory distress and morbidity in late preterm and term neonates presenting with TTN.


Options:
A: Arm Label: Inhaled steroids (Budicort); Type: EXPERIMENTAL; Interventions: Drug: Experimental group: Budicort by Inhalation | Arm Label: Control; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Intervention Type: DRUG; Name: Experimental group: Budicort by Inhalation; Assigned to Arm(s): Inhaled steroids (Budicort) | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): Control
B: Arm Label: Standard Fluids; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Restricted Fluids; Type: EXPERIMENTAL; Interventions: Other: Amount of total fluids | Intervention Type: OTHER; Name: Amount of total fluids; Assigned to Arm(s): Restricted Fluids
C: Arm Label: Neopuff group; Type: EXPERIMENTAL; Interventions: Device: Neopuff | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Neopuff; Assigned to Arm(s): Neopuff group
D: Arm Label: nHFPV; Type: EXPERIMENTAL; Interventions: Procedure: Intrapulmonary Percussive Ventilation | Arm Label: nCPAP; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Nasal Continuous Positive Airway Pressure ventilation | Intervention Type: PROCEDURE; Name: Nasal Continuous Positive Airway Pressure ventilation; Assigned to Arm(s): nCPAP | Intervention Type: PROCEDURE; Name: Intrapulmonary Percussive Ventilation; Assigned to Arm(s): nHFPV

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Prospective, Randomized, Multi-center, Single-blinded Study for the Treatment of Subjects Presenting With De Novo Occluded/Stenotic or Re-occluded/Restenotic Lesions of the Superficial Femoral or Popliteal Arteries Using Paclitaxel or Bare Percutaneous Transluminal Angioplasty Balloon Catheter
Brief Summary: This is a prospective, randomized, multi-center, single-blind study to demonstrate the safety and effectiveness of the CVI Paclitaxel-coated percutaneous transluminal angioplasty (PTA) balloon versus bare PTA balloon for the treatment of patients with de novo occluded/stenotic or reoccluded/restenotic lesions of the superficial femoral (SFA) and popliteal arteries.


Options:
A: Arm Label: Stenting; Type: ACTIVE_COMPARATOR; Interventions: Device: Stenting (Smart Stent) | Arm Label: Stenting after PEB; Type: EXPERIMENTAL; Interventions: Device: Stenting (Smart Stent), Device: Stenting after PEB (Smart Stent, Invatec) | Arm Label: Atherectomy; Type: EXPERIMENTAL; Interventions: Procedure: Atherectomy (SilverHawk device) | Intervention Type: DEVICE; Name: Stenting (Smart Stent); Assigned to Arm(s): Stenting, Stenting after PEB | Intervention Type: DEVICE; Name: Stenting after PEB (Smart Stent, Invatec); Assigned to Arm(s): Stenting after PEB | Intervention Type: PROCEDURE; Name: Atherectomy (SilverHawk device); Assigned to Arm(s): Atherectomy
B: Arm Label: Rotational Atherectomy + PES; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Rotational Atherectomy + PES | Arm Label: Standard Treatment (PES without Rotational Atherectomy); Type: ACTIVE_COMPARATOR; Interventions: Procedure: Standard Treatment (PES without Rotational Atherectomy) | Intervention Type: PROCEDURE; Name: Rotational Atherectomy + PES; Assigned to Arm(s): Rotational Atherectomy + PES | Intervention Type: PROCEDURE; Name: Standard Treatment (PES without Rotational Atherectomy); Assigned to Arm(s): Standard Treatment (PES without Rotational Atherectomy)
C: Arm Label: Paclitaxel-coated balloon; Type: EXPERIMENTAL; Interventions: Device: CVI Paclitaxel-coated Percutaneous Transluminal Angioplasty Balloon Catheter | Arm Label: Bare balloon; Type: PLACEBO_COMPARATOR; Interventions: Device: Bare Percutaneous Transluminal Angioplasty Balloon Catheter | Intervention Type: DEVICE; Name: CVI Paclitaxel-coated Percutaneous Transluminal Angioplasty Balloon Catheter; Assigned to Arm(s): Paclitaxel-coated balloon | Intervention Type: DEVICE; Name: Bare Percutaneous Transluminal Angioplasty Balloon Catheter; Assigned to Arm(s): Bare balloon
D: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Other: Percutaneous Transluminal Angioplasty | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Device: LifeStent NT™ Self-Expanding Peripheral Stent | Intervention Type: OTHER; Name: Percutaneous Transluminal Angioplasty; Assigned to Arm(s): 1 | Intervention Type: DEVICE; Name: LifeStent NT™ Self-Expanding Peripheral Stent; Assigned to Arm(s): 2

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Efficacy of Intravenous Paracetamol Versus Dipyrone for Postoperative Analgesia After Day-case Lower Abdominal Surgery in Children With Spinal Anesthesia: a Prospective Randomized Double-blind Study
Brief Summary: We conducted a prospective, randomized double-blind study to compare the effectiveness of intravenous paracetamol and dipyrone for preventing pain during early postoperative period in school-age children undergoing lower abdominal surgery with spinal anesthesia.


Options:
A: Arm Label: Paracetamol; Type: EXPERIMENTAL; Interventions: Drug: Paracetamol | Arm Label: Morphine; Type: EXPERIMENTAL; Interventions: Drug: Morphine | Arm Label: Paracetamol-morphine; Type: EXPERIMENTAL; Interventions: Drug: Paracetamol- Morphine | Intervention Type: DRUG; Name: Paracetamol; Assigned to Arm(s): Paracetamol | Intervention Type: DRUG; Name: Morphine; Assigned to Arm(s): Morphine | Intervention Type: DRUG; Name: Paracetamol- Morphine; Assigned to Arm(s): Paracetamol-morphine
B: Arm Label: IV Placebo 100 ml; Type: PLACEBO_COMPARATOR; Interventions: Drug: IV Placebo | Arm Label: IV Placebo 65 ml; Type: PLACEBO_COMPARATOR; Interventions: Drug: IV Placebo | Arm Label: IV Acetaminophen 1 gm; Type: EXPERIMENTAL; Interventions: Drug: IV Acetaminophen | Arm Label: IV Acetaminophen 650 mg; Type: EXPERIMENTAL; Interventions: Drug: IV Acetaminophen | Intervention Type: DRUG; Name: IV Placebo; Assigned to Arm(s): IV Placebo 100 ml | Intervention Type: DRUG; Name: IV Placebo; Assigned to Arm(s): IV Placebo 65 ml | Intervention Type: DRUG; Name: IV Acetaminophen; Assigned to Arm(s): IV Acetaminophen 1 gm | Intervention Type: DRUG; Name: IV Acetaminophen; Assigned to Arm(s): IV Acetaminophen 650 mg
C: Arm Label: Lornoxicam; Type: EXPERIMENTAL; Interventions: Drug: Lornoxicam | Arm Label: Control; Type: PLACEBO_COMPARATOR; Interventions: Other: placebo | Arm Label: Paracetamol; Type: EXPERIMENTAL; Interventions: Drug: Paracetamol | Intervention Type: OTHER; Name: placebo; Assigned to Arm(s): Control | Intervention Type: DRUG; Name: Paracetamol; Assigned to Arm(s): Paracetamol | Intervention Type: DRUG; Name: Lornoxicam; Assigned to Arm(s): Lornoxicam
D: Arm Label: Paracetamol; Type: ACTIVE_COMPARATOR; Interventions: Drug: Paracetamol | Arm Label: Dipyrone; Type: ACTIVE_COMPARATOR; Interventions: Drug: Dipyrone | Intervention Type: DRUG; Name: Paracetamol; Assigned to Arm(s): Paracetamol | Intervention Type: DRUG; Name: Dipyrone; Assigned to Arm(s): Dipyrone

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Prospective, Comparative, Randomized, Controlled Trial on the Efficacy of the Treatment of Gastroesophageal Reflux Infant With Magnesium Alginate
Brief Summary: The results on the efficacy of the formulations based on alginic acid are controversial. Corvaglia et al demonstrated a significant reduction in reflux episodes in preterm infants by evaluation with pH-impedance analysis. This study concludes that the use of alginic acid reduces the acidity of the gastroesophageal reflux (GER) and has a non-systemic effect and a lesser presence of side effects compared to the use of H2-receptor antagonist(H2RA) and proton pump inhibitor (PPI).


Options:
A: Intervention Type: DRUG; Name: pantoprazole for approximately 9 weeks.; Assigned to Arm(s): N/A
B: Intervention Type: DRUG; Name: Esomeprazole (Nexium); Assigned to Arm(s): N/A
C: Arm Label: Gastrotuss; Type: EXPERIMENTAL; Interventions: Drug: Gastrotuss | Arm Label: Thickened Formula; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: thickened milk | Arm Label: control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: Gastrotuss; Assigned to Arm(s): Gastrotuss | Intervention Type: DIETARY_SUPPLEMENT; Name: thickened milk; Assigned to Arm(s): Thickened Formula
D: Arm Label: Rabeprazole 0.5 mg/kg; Type: EXPERIMENTAL; Interventions: Drug: rabeprazole | Arm Label: Rabeprazole 1.0 mg/kg; Type: EXPERIMENTAL; Interventions: Drug: rabeprazole | Intervention Type: DRUG; Name: rabeprazole; Assigned to Arm(s): Rabeprazole 0.5 mg/kg | Intervention Type: DRUG; Name: rabeprazole; Assigned to Arm(s): Rabeprazole 1.0 mg/kg

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Adherence Enhancement for Renal Transplant Patients
Brief Summary: Despite significant advances in the care of kidney transplant recipients, long term graft survival after renal transplantation remains suboptimal. Medication nonadherence and clinical inertia are key contributors to graft loss. The purpose of the proposed RCT feasibility study is to evaluate impact of a "bundled" wireless real time medication reminder system and blood pressure monitoring system in combination with a cognitive behavioral adherence skills enhancement program upon medication adherence, therapeutic drug concentration, and blood pressure, in nonadherent kidney transplant recipients with hypertension. We propose to recruit 60 kidney transplant recipients in phase 1 with 20 non-adherent continuing to phase 2 for a 5-month feasibility RCT.


Options:
A: Arm Label: Standard of Care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: TMITT; Type: ACTIVE_COMPARATOR; Interventions: Other: Transplant Medication Information Teaching Tool | Intervention Type: OTHER; Name: Transplant Medication Information Teaching Tool; Assigned to Arm(s): TMITT
B: Arm Label: Standard Care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: mHealth; Type: EXPERIMENTAL; Interventions: Behavioral: mHealth | Intervention Type: BEHAVIORAL; Name: mHealth; Assigned to Arm(s): mHealth
C: Arm Label: Tacrolimus twice-daily; Type: ACTIVE_COMPARATOR; Interventions: Drug: Tacrolimus twice daily | Arm Label: Envarsus XR; Type: ACTIVE_COMPARATOR; Interventions: Drug: Envarsus XR | Intervention Type: DRUG; Name: Envarsus XR; Assigned to Arm(s): Envarsus XR | Intervention Type: DRUG; Name: Tacrolimus twice daily; Assigned to Arm(s): Tacrolimus twice-daily
D: Arm Label: Multi-component Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Action-focused problem-solving, Device: Electronic pillbox monitoring, dose reminders, and feedback | Arm Label: Attention control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Action-focused problem-solving; Assigned to Arm(s): Multi-component Intervention | Intervention Type: DEVICE; Name: Electronic pillbox monitoring, dose reminders, and feedback; Assigned to Arm(s): Multi-component Intervention

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Adherence Enhancement for Renal Transplant Patients
Brief Summary: Despite significant advances in the care of kidney transplant recipients, long term graft survival after renal transplantation remains suboptimal. Medication nonadherence and clinical inertia are key contributors to graft loss. The purpose of the proposed RCT feasibility study is to evaluate impact of a "bundled" wireless real time medication reminder system and blood pressure monitoring system in combination with a cognitive behavioral adherence skills enhancement program upon medication adherence, therapeutic drug concentration, and blood pressure, in nonadherent kidney transplant recipients with hypertension. We propose to recruit 60 kidney transplant recipients in phase 1 with 20 non-adherent continuing to phase 2 for a 5-month feasibility RCT.


Options:
A: Arm Label: Multi-component Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Action-focused problem-solving, Device: Electronic pillbox monitoring, dose reminders, and feedback | Arm Label: Attention control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Action-focused problem-solving; Assigned to Arm(s): Multi-component Intervention | Intervention Type: DEVICE; Name: Electronic pillbox monitoring, dose reminders, and feedback; Assigned to Arm(s): Multi-component Intervention
B: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Behavioral Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Behavioral Interventions for Dialysis Facilities | Intervention Type: BEHAVIORAL; Name: Behavioral Interventions for Dialysis Facilities; Assigned to Arm(s): Behavioral Intervention
C: Arm Label: Standard Care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: mHealth; Type: EXPERIMENTAL; Interventions: Behavioral: mHealth | Intervention Type: BEHAVIORAL; Name: mHealth; Assigned to Arm(s): mHealth
D: Arm Label: SCT-based behavioral intervention; Type: EXPERIMENTAL; Interventions: Behavioral: SCT-based behavioral intervention | Arm Label: Attention control; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Attention Control | Intervention Type: BEHAVIORAL; Name: SCT-based behavioral intervention; Assigned to Arm(s): SCT-based behavioral intervention | Intervention Type: BEHAVIORAL; Name: Attention Control; Assigned to Arm(s): Attention control

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Adherence Enhancement for Renal Transplant Patients
Brief Summary: Despite significant advances in the care of kidney transplant recipients, long term graft survival after renal transplantation remains suboptimal. Medication nonadherence and clinical inertia are key contributors to graft loss. The purpose of the proposed RCT feasibility study is to evaluate impact of a "bundled" wireless real time medication reminder system and blood pressure monitoring system in combination with a cognitive behavioral adherence skills enhancement program upon medication adherence, therapeutic drug concentration, and blood pressure, in nonadherent kidney transplant recipients with hypertension. We propose to recruit 60 kidney transplant recipients in phase 1 with 20 non-adherent continuing to phase 2 for a 5-month feasibility RCT.


Options:
A: Arm Label: Standard Care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: mHealth; Type: EXPERIMENTAL; Interventions: Behavioral: mHealth | Intervention Type: BEHAVIORAL; Name: mHealth; Assigned to Arm(s): mHealth
B: Arm Label: A; Type: EXPERIMENTAL; Interventions: Behavioral: dietary education | Intervention Type: BEHAVIORAL; Name: dietary education; Assigned to Arm(s): A
C: Arm Label: Symptom management nurse intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Symptom management nurse intervention | Arm Label: Feedback intervention; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Feedback intervention | Intervention Type: BEHAVIORAL; Name: Symptom management nurse intervention; Assigned to Arm(s): Symptom management nurse intervention | Intervention Type: BEHAVIORAL; Name: Feedback intervention; Assigned to Arm(s): Feedback intervention
D: Arm Label: SCT-based behavioral intervention; Type: EXPERIMENTAL; Interventions: Behavioral: SCT-based behavioral intervention | Arm Label: Attention control; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Attention Control | Intervention Type: BEHAVIORAL; Name: SCT-based behavioral intervention; Assigned to Arm(s): SCT-based behavioral intervention | Intervention Type: BEHAVIORAL; Name: Attention Control; Assigned to Arm(s): Attention control

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Stepped Care - Optimising Psycho-oncological Care Provision by Structured Screening and Diagnosis
Brief Summary: The study will examine whether the provision of psychosocial support services for cancer patients in acute care can be optimized by the use of a structured combination of screening procedures with physician interviews and structured patient pathways.

There is strong evidence that a third of all cancer patients in acute care are suffering from mental health conditions and that a third expresses the need for professional psycho-oncological support.

However, physicians and nurses do not always identify these patients in need for support. Screening questionnaires are significantly better to identify distressed patients however the use of screenings alone does not necessarily improve the patients' emotional well-being.

Purpose of this study is to evaluate a psychosocial stepped care model which aims to decrease the patients' distress.


Options:
A: Intervention Type: BEHAVIORAL; Name: Community Interlink Program; Assigned to Arm(s): N/A
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Meaning Centered Group Psychotherapy | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Supportive Group Psychotherapy | Intervention Type: BEHAVIORAL; Name: Meaning Centered Group Psychotherapy; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Supportive Group Psychotherapy; Assigned to Arm(s): 2
C: Arm Label: Intervention group 1; Type: EXPERIMENTAL; Interventions: Other: Questionnaire administration | Arm Label: Intervention group 2; Type: EXPERIMENTAL; Interventions: Other: Questionnaire administration | Arm Label: Control group 1; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Control group 2; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Questionnaire administration; Assigned to Arm(s): Intervention group 1, Intervention group 2
D: Arm Label: Stepped Care; Type: EXPERIMENTAL; Interventions: Other: Stepped Care | Arm Label: Care as usual; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Stepped Care; Assigned to Arm(s): Stepped Care

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Stepped Care - Optimising Psycho-oncological Care Provision by Structured Screening and Diagnosis
Brief Summary: The study will examine whether the provision of psychosocial support services for cancer patients in acute care can be optimized by the use of a structured combination of screening procedures with physician interviews and structured patient pathways.

There is strong evidence that a third of all cancer patients in acute care are suffering from mental health conditions and that a third expresses the need for professional psycho-oncological support.

However, physicians and nurses do not always identify these patients in need for support. Screening questionnaires are significantly better to identify distressed patients however the use of screenings alone does not necessarily improve the patients' emotional well-being.

Purpose of this study is to evaluate a psychosocial stepped care model which aims to decrease the patients' distress.


Options:
A: Arm Label: Stepped Care; Type: EXPERIMENTAL; Interventions: Other: Stepped Care | Arm Label: Care as usual; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Stepped Care; Assigned to Arm(s): Stepped Care
B: Arm Label: Connected device; Type: EXPERIMENTAL; Interventions: Device: Connected device | Arm Label: Therapeutic education; Type: EXPERIMENTAL; Interventions: Behavioral: Therapeutic education | Arm Label: Combined; Type: EXPERIMENTAL; Interventions: Device: Connected device, Behavioral: Therapeutic education | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Connected device; Assigned to Arm(s): Combined, Connected device | Intervention Type: BEHAVIORAL; Name: Therapeutic education; Assigned to Arm(s): Combined, Therapeutic education
C: Arm Label: Bone marrow transplantation; Type: OTHER; Interventions: Procedure: Bone marrow transplantation | Arm Label: Peripheral blood stem cell transplantation; Type: OTHER; Interventions: Procedure: Peripheral blood stem cell transplantation | Intervention Type: PROCEDURE; Name: Bone marrow transplantation; Assigned to Arm(s): Bone marrow transplantation | Intervention Type: PROCEDURE; Name: Peripheral blood stem cell transplantation; Assigned to Arm(s): Peripheral blood stem cell transplantation
D: Arm Label: Experimetal Arm; Type: EXPERIMENTAL; Interventions: Behavioral: Tailored health partnership program | Arm Label: Control Arm; Type: NO_INTERVENTION; Interventions: Behavioral: Usual care and health education workshop | Intervention Type: BEHAVIORAL; Name: Tailored health partnership program; Assigned to Arm(s): Experimetal Arm | Intervention Type: BEHAVIORAL; Name: Usual care and health education workshop; Assigned to Arm(s): Control Arm

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Positive End Expiratory Pressure With A T-piece Resuscitator (Neopuff) For Near-Term and Term Infants With Respiratory Distress: A Randomized, Controlled Trial
Brief Summary: Evaluating the effect of early application of Continuous positive airway pressure (CPAP) via Neopuff in cases of transient tachypnea of the newborn(TTN) and its role in decreasing the duration and complication of TTN.


Options:
A: Arm Label: Inhaled steroids (Budicort); Type: EXPERIMENTAL; Interventions: Drug: Experimental group: Budicort by Inhalation | Arm Label: Control; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Intervention Type: DRUG; Name: Experimental group: Budicort by Inhalation; Assigned to Arm(s): Inhaled steroids (Budicort) | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): Control
B: Arm Label: Standard Fluids; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Restricted Fluids; Type: EXPERIMENTAL; Interventions: Other: Amount of total fluids | Intervention Type: OTHER; Name: Amount of total fluids; Assigned to Arm(s): Restricted Fluids
C: Arm Label: nHFPV; Type: EXPERIMENTAL; Interventions: Procedure: Intrapulmonary Percussive Ventilation | Arm Label: nCPAP; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Nasal Continuous Positive Airway Pressure ventilation | Intervention Type: PROCEDURE; Name: Nasal Continuous Positive Airway Pressure ventilation; Assigned to Arm(s): nCPAP | Intervention Type: PROCEDURE; Name: Intrapulmonary Percussive Ventilation; Assigned to Arm(s): nHFPV
D: Arm Label: Neopuff group; Type: EXPERIMENTAL; Interventions: Device: Neopuff | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Neopuff; Assigned to Arm(s): Neopuff group

Answer: D